nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipecuronium—BCHE—Synthesis of PC—CHKB—narcolepsy	0.104	0.129	CbGpPWpGaD
Pipecuronium—BCHE—Glycerophospholipid biosynthesis—CHKB—narcolepsy	0.0306	0.0378	CbGpPWpGaD
Pipecuronium—CHRNA2—forebrain—narcolepsy	0.0286	0.151	CbGeAlD
Pipecuronium—BCHE—Phospholipid metabolism—CHKB—narcolepsy	0.0213	0.0263	CbGpPWpGaD
Pipecuronium—CHRM3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0208	0.0257	CbGpPWpGaD
Pipecuronium—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0206	0.0254	CbGpPWpGaD
Pipecuronium—CHRM3—GPCRs, Other—P2RY11—narcolepsy	0.0195	0.024	CbGpPWpGaD
Pipecuronium—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.0193	0.0238	CbGpPWpGaD
Pipecuronium—CHRNB1—medulla oblongata—narcolepsy	0.0192	0.101	CbGeAlD
Pipecuronium—CHRNB1—midbrain—narcolepsy	0.0176	0.0925	CbGeAlD
Pipecuronium—CHRM2—forebrain—narcolepsy	0.0171	0.0898	CbGeAlD
Pipecuronium—CHRNA1—brain—narcolepsy	0.0143	0.0753	CbGeAlD
Pipecuronium—CHRM3—forebrain—narcolepsy	0.0139	0.0732	CbGeAlD
Pipecuronium—CHRM3—Monoamine GPCRs—HTR2A—narcolepsy	0.0123	0.0152	CbGpPWpGaD
Pipecuronium—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.0122	0.0151	CbGpPWpGaD
Pipecuronium—CHRNA2—brain—narcolepsy	0.0119	0.0625	CbGeAlD
Pipecuronium—BCHE—brainstem—narcolepsy	0.0118	0.0619	CbGeAlD
Pipecuronium—BCHE—forebrain—narcolepsy	0.0113	0.0597	CbGeAlD
Pipecuronium—CHRM3—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0113	0.014	CbGpPWpGaD
Pipecuronium—CHRM3—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0113	0.014	CbGpPWpGaD
Pipecuronium—CHRNB1—brain—narcolepsy	0.0111	0.0581	CbGeAlD
Pipecuronium—CHRM3—G alpha (q) signalling events—P2RY11—narcolepsy	0.0109	0.0135	CbGpPWpGaD
Pipecuronium—CHRM3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0104	0.0128	CbGpPWpGaD
Pipecuronium—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0103	0.0127	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0101	0.0125	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0101	0.0125	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00978	0.0121	CbGpPWpGaD
Pipecuronium—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.0093	0.0115	CbGpPWpGaD
Pipecuronium—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00876	0.0108	CbGpPWpGaD
Pipecuronium—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00876	0.0108	CbGpPWpGaD
Pipecuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00867	0.0107	CbGpPWpGaD
Pipecuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00867	0.0107	CbGpPWpGaD
Pipecuronium—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00846	0.0104	CbGpPWpGaD
Pipecuronium—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00837	0.0103	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00832	0.0103	CbGpPWpGaD
Pipecuronium—BCHE—medulla oblongata—narcolepsy	0.0082	0.0431	CbGeAlD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0075	0.00926	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0075	0.00926	CbGpPWpGaD
Pipecuronium—BCHE—midbrain—narcolepsy	0.00749	0.0394	CbGeAlD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00743	0.00917	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00743	0.00917	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00725	0.00895	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00718	0.00886	CbGpPWpGaD
Pipecuronium—CHRM2—brain—narcolepsy	0.00708	0.0373	CbGeAlD
Pipecuronium—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.00705	0.0087	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00687	0.00848	CbGpPWpGaD
Pipecuronium—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.00684	0.00844	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00631	0.00778	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00616	0.00761	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0061	0.00753	CbGpPWpGaD
Pipecuronium—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00586	0.00724	CbGpPWpGaD
Pipecuronium—CHRM3—brain—narcolepsy	0.00577	0.0304	CbGeAlD
Pipecuronium—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00571	0.00705	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00571	0.00705	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00566	0.00699	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00566	0.00699	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00552	0.00681	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00549	0.00678	CbGpPWpGaD
Pipecuronium—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00548	0.00677	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00546	0.00675	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00544	0.00671	CbGpPWpGaD
Pipecuronium—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00543	0.0067	CbGpPWpGaD
Pipecuronium—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00512	0.00632	CbGpPWpGaD
Pipecuronium—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00512	0.00632	CbGpPWpGaD
Pipecuronium—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.0051	0.0063	CbGpPWpGaD
Pipecuronium—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00478	0.0059	CbGpPWpGaD
Pipecuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00473	0.00584	CbGpPWpGaD
Pipecuronium—BCHE—brain—narcolepsy	0.00471	0.0248	CbGeAlD
Pipecuronium—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00469	0.00579	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00467	0.00577	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00467	0.00576	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00465	0.00574	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00462	0.00571	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00458	0.00566	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00458	0.00566	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00418	0.00516	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00414	0.00511	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00409	0.00505	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00405	0.00501	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00356	0.00439	CbGpPWpGaD
Pipecuronium—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00353	0.00436	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00352	0.00435	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00339	0.00419	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00339	0.00419	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00336	0.00415	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00336	0.00415	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00323	0.00399	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00323	0.00399	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.0032	0.00395	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.0032	0.00395	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00312	0.00385	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00312	0.00385	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00309	0.00381	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00309	0.00381	CbGpPWpGaD
Pipecuronium—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00308	0.0038	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—CHKB—narcolepsy	0.00306	0.00378	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00293	0.00362	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00293	0.00362	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.0029	0.00358	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.0029	0.00358	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00283	0.0035	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.0028	0.00346	CbGpPWpGaD
Pipecuronium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00276	0.0034	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00265	0.00327	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00263	0.00324	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00258	0.00319	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00258	0.00319	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00256	0.00316	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00256	0.00316	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00241	0.00297	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00238	0.00294	CbGpPWpGaD
Pipecuronium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00238	0.00294	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00236	0.00292	CbGpPWpGaD
Pipecuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00236	0.00291	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—CHKB—narcolepsy	0.00235	0.0029	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00234	0.00289	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00215	0.00265	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00213	0.00262	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—CPT1B—narcolepsy	0.00208	0.00257	CbGpPWpGaD
Pipecuronium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00204	0.00252	CbGpPWpGaD
Pipecuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00202	0.0025	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00201	0.00248	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00199	0.00246	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00182	0.00225	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00181	0.00223	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00176	0.00218	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00174	0.00215	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00173	0.00214	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00173	0.00214	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00172	0.00212	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00172	0.00212	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00167	0.00207	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00166	0.00205	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.0016	0.00198	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—CPT1B—narcolepsy	0.0016	0.00197	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00158	0.00196	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00155	0.00192	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00154	0.0019	CbGpPWpGaD
Pipecuronium—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00152	0.00187	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.00146	0.0018	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.00146	0.0018	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.00145	0.00178	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.00145	0.00178	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00142	0.00176	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.00141	0.00174	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.00133	0.00164	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.00133	0.00164	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00131	0.00162	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00131	0.00162	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—PENK—narcolepsy	0.00127	0.00157	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—PENK—narcolepsy	0.00126	0.00155	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—TRH—narcolepsy	0.00108	0.00133	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00107	0.00132	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000945	0.00117	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000936	0.00116	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000878	0.00108	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.00087	0.00107	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000798	0.000985	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.00079	0.000975	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000783	0.000967	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000783	0.000967	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000776	0.000958	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000776	0.000958	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000471	0.000582	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000467	0.000576	CbGpPWpGaD
